Drug Shortage Report for MYLAN-VERAPAMIL SR
| Report ID | 79724 |
| Drug Identification Number | 02210347 |
| Brand name | MYLAN-VERAPAMIL SR |
| Common or Proper name | VERAPAMIL SR |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Strength(s) | 120MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 BT |
| ATC code | C08DA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2019-04-03 |
| Actual start date | |
| Estimated end date | 2019-05-30 |
| Actual end date | 2019-04-10 |
| Shortage status | Resolved |
| Updated date | 2019-04-11 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.